WHO says remdesivir has little effect in hospitalized Covid-19 — but Gilead calls new data 'inconsistent' with previous findings
A new WHO study is throwing cold water on the effectiveness on remdesivir in Covid-19 patients.
After conducting a large clinical trial looking into remdesivir and three other treatments, the WHO has found that none had any substantial effect on improving mortality rates, reducing the amount of patients needing ventilators or shortening hospital stays. The other therapies in the study were hydroxychloroquine, lopinavir and interferon.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.